SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Want No Buyout; Would be a Big Loss

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
falconer66a Member Profile
 
Followed By 56
Posts 552
Boards Moderated 0
Alias Born 01/29/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/16/2017 11:07:52 AM
Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Pat... "GlobeNewswire Inc." - 10/12/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2017 5:18:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/5/2017 5:57:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 7:53:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/29/2017 2:33:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2017 3:10:51 PM
Anavex Life Sciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference "GlobeNewswire Inc." - 9/21/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/20/2017 4:51:51 PM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2017 1:59:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/14/2017 2:28:25 PM
Alzheimer’s Disease: Cannabis Formulation Shows Promise "NetworkNewsWire" - 9/12/2017 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/8/2017 7:21:13 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 9/7/2017 3:17:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 2:22:14 PM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX™ 2-73 "GlobeNewswire Inc." - 9/5/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/31/2017 2:46:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/29/2017 11:13:56 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/25/2017 2:20:18 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/21/2017 11:43:39 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 4:55:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 5:15:55 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/11/2017 5:22:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/11/2017 4:42:04 PM
falconer66a   Saturday, 08/12/17 03:41:59 PM
Re: tradeherpete post# 115239
Post # of 124962 
Want No Buyout; Would be a Big Loss

Quote:
And some of them might even buy us and them.



Of course, the prospects of a near-term purchase of Anavex Life Sciences Corp by an existing Big Pharmaceutical can be enticing.

But I doubt any near-term buyout could or would match Anavex's future, all-by-itself value. After FDA approval of Anavex 2-73 for the never-bettered treatment of several global neurodegenerative diseases (Alzheimer's, Parkinson's, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, et al.), the share price of AVXL will be in the high hundreds, if not low thousands.

Anyone wish to tell their lowest price they'd sell their shares to another company?

Me? I'll sell all of my modest AVXL position for $1000 per share.

(But that might not be wise, considering the perpetuating and enduring big dividends I would be giving up.)


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist